Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations

Evaluation of Early-Stage Parkinson’s Disease with 99mTc-TRODAT-1 Imaging

Wen-Sheng Huang, Shinn-Zong Lin, Jiann-Chyun Lin, Shiaw-Pyng Wey, Gann Ting and Ren-Shyan Liu
Journal of Nuclear Medicine September 2001, 42 (9) 1303-1308;
Wen-Sheng Huang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinn-Zong Lin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiann-Chyun Lin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiaw-Pyng Wey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gann Ting
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ren-Shyan Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    99mTc-TRODAT-1 SPECT in transverse views of healthy volunteer (A) and of patients with HYS stage I (B) and stage II (C) Parkinson’s disease. Asymmetric striatal uptake was observed, with more profound loss contralateral to symptoms or more affected limbs.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Specific striatal uptake of 99mTc-TRODAT-1 in healthy volunteers and in patients with HYS stage I and stage II Parkinson’s disease.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Specific putaminal uptake of 99mTc-TRODAT-1 in healthy volunteers and in patients with HYS stage I and stage II Parkinson’s disease.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Specific putaminal uptake of 99mTc-TRODAT-1 in healthy volunteers and in patients with HYS stage I Parkinson’s disease contralateral and ipsilateral to symptoms.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Specific putaminal uptake of 99mTc-TRODAT-1 in healthy volunteers and in patients with HYS stage II Parkinson’s disease contralateral and ipsilateral to symptoms.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Specific posterior putaminal uptake of 99mTc-TRODAT-1 in healthy volunteers and in patients with HYS stage I Parkinson’s disease ipsilateral to symptoms.

Tables

  • Figures
    • View popup
    TABLE 1

    Specific Uptake of 99mTc-TRODAT-1 in Striatum and Subregions in Patients with Early Parkinson’s Disease

    RegionHealthy volunteersStage I Parkinson’s diseaseStage II Parkinson’s disease
    Striatum1.98 ± 0.241.62 ± 0.11*1.22 ± 0.12*
    Putamen
     Total1.81 ± 0.181.27 ± 0.14*0.94 ± 0.20*
     Contralateral1.02 ± 0.200.73 ± 0.19
     Ipsilateral1.49 ± 0.22†1.14 ± 0.29†
    Caudate
     Total2.13 ± 0.311.97 ± 0.211.51 ± 0.17*
     Contralateral1.95 ± 0.221.45 ± 0.24
     Ipsilateral1.99 ± 0.341.58 ± 0.23‡
    • ↵*P < 0.01 compared with volunteers or adjacent group.

    • ↵†P < 0.01 compared with volunteers or contralateral side.

    • ↵‡P < 0.01 compared with volunteers only.

    • Data are expressed as mean ± SD. Contralateral means side opposite to symptoms or more affected limbs. Ipsilateral means side of symptoms or more affected limbs.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 42, Issue 9
September 1, 2001
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of Early-Stage Parkinson’s Disease with 99mTc-TRODAT-1 Imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Evaluation of Early-Stage Parkinson’s Disease with 99mTc-TRODAT-1 Imaging
Wen-Sheng Huang, Shinn-Zong Lin, Jiann-Chyun Lin, Shiaw-Pyng Wey, Gann Ting, Ren-Shyan Liu
Journal of Nuclear Medicine Sep 2001, 42 (9) 1303-1308;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evaluation of Early-Stage Parkinson’s Disease with 99mTc-TRODAT-1 Imaging
Wen-Sheng Huang, Shinn-Zong Lin, Jiann-Chyun Lin, Shiaw-Pyng Wey, Gann Ting, Ren-Shyan Liu
Journal of Nuclear Medicine Sep 2001, 42 (9) 1303-1308;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Can we image premotor Parkinson disease?
  • Parkinson disease: Handedness predicts asymmetry
  • [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease
  • Sensitivity and Specificity of 99mTc-TRODAT-1 SPECT Imaging in Differentiating Patients with Idiopathic Parkinson's Disease from Healthy Subjects
  • Reproducibility of 99mTc-TRODAT-1 SPECT Measurement of Dopamine Transporters in Parkinson's Disease
  • 99mTc-TRODAT-1 Imaging of Multiple System Atrophy
  • Imaging the dopamine system to assess disease-modifying drugs: Studies comparing dopamine agonists and levodopa
  • Crossover Study of 99mTc-TRODAT-1 SPECT and 18F-FDOPA PET in Parkinson's Disease Patients
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire